Cleared Traditional

Ceevra Reveal 2.0 (K173274) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K173274 · Ceevra, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2018
Decision
271d
Days
Class 2
Risk

K173274 is an FDA 510(k) clearance for the Ceevra Reveal 2.0. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Ceevra, Inc. (San Francisco, US). The FDA issued a Cleared decision on July 10, 2018 after a review of 271 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate-to-high equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Ceevra, Inc. devices

Submission Details

510(k) Number K173274 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 12, 2017
Decision Date July 10, 2018
Days to Decision 271 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
164d slower than avg
Panel avg: 107d · This submission: 271d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Rac Medical, LLC
Rory A. Carrillo

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 797
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K173274.
miPlatform medical imaging suite v3.0 (miPlatform v3.0), miPlatform ZFP Viewer
K171977 · Hinacom Software and Technology, Ltd. · Aug 2018
Quantitative Total Extensible Imaging (QTxI)
K173444 · Aiq Solutions, Inc. · Jul 2018
DentiqGuide
K180629 · 3D Industrial Imaging Co., Ltd. · Jul 2018
DenSeeMammo
K173574 · Statlife · Jun 2018
MIM - SPECTRA Quant
K180815 · Mim Software, Inc. · Jun 2018
sterEOS Workstation
K172346 · Eos Imaging · Jun 2018